Pharmacy Question for the Week of July 31, 2017

Question:

Can you provide any information related to the CMS plan to decrease the 340B program payments in 2018?

Answer:

For 2018, the Centers for Medicare & Medicaid Services (CMS) has proposed paying providers purchasing drugs under the 340B program at significantly lower rates. Specifically, for separately payable drugs and biologicals (other than drugs on pass-through and vaccines) acquired under the 340B program from the average sales price  (ASP) plus 6 percent to ASP minus 22.5 percent. In addition, CMS stated its intent to establish a modifier to identify whether a drug billed under the OPPS was purchased under the 340B Drug Discount Program.

The proposed rule (CMS-1678-P) can be downloaded from the Federal Register at https://www.federalregister.gov/public-inspection/2017/07/13.

Print Friendly, PDF & Email
Facebook
Twitter
LinkedIn

CPT® copyright 2023 American Medical Association (AMA). All rights reserved.

Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

CPT is a registered trademark of the American Medical Association.

SPRING INTO SAVINGS! Get 21% OFF during our exclusive two-day sale starting 3/21/2024. Use SPRING24 at checkout to claim this offer. Click here to learn more →